| 07/28 | NOVOCURE : Q2 Earnings Snapshot | AQ |
| 07/28 | NOVOCURE : Quarterly net revenues of $140.9 million, a 6% increase year-over-year - Form 8.. | PU |
| 07/28 | Novocure Reports Second Quarter 2022 Financial Results | BU |
| 07/28 | NOVOCURE LTD Management's Discussion and Analysis of Financial Condition and Results
o.. | AQ |
| 07/27 | Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fie.. | BU |
| 07/01 | Novocure to Report Second Quarter 2022 Financial Results | BU |
| 06/21 | Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T.. | BU |
| 06/10 | NOVOCURE LTD : Change in Directors or Principal Officers, Amendments to Articles of Inc. o.. | AQ |
| 06/03 | NOVOCURE : Press Release of NovoCure Limited, dated June 3, 2022 - Form 8-K | PU |
| 06/03 | NOVOCURE LTD : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 06/03 | Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field.. | BU |
| 05/26 | NOVOCURE : Announces Clinical Collaboration with MSD on a Registrational-Intent Study to E.. | PU |
| 05/26 | NOVOCURE LTD : Entry into a Material Definitive Agreement, Other Events, Financial Stateme.. | AQ |
| 05/26 | Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to .. | BU |
| 04/28 | NOVOCURE : Q1 Earnings Snapshot | AQ |
| 04/28 | NOVOCURE : Quarterly net revenues of $137.5 million with 80% gross margin - Form 8-K | PU |
| 04/28 | NOVOCURE LTD Management's Discussion and Analysis of Financial Condition and Results
o.. | AQ |
| 04/28 | Novocure Reports First Quarter 2022 Financial Results | BU |
| 04/19 | Novocure Hosts Ceremonial Groundbreaking with New Hampshire Governor Chris Sununu | BU |
| 04/13 | NOVOCURE LTD : Change in Directors or Principal Officers, Financial Statements and Exhibit.. | AQ |
| 04/08 | Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) .. | BU |
| 04/07 | NOVOCURE LTD : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 04/01 | Novocure to Report First Quarter 2022 Financial Results | BU |
| 03/24 | Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survi.. | BU |
| 03/23 | Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 .. | BU |
| 03/23 | NOVOCURE LTD : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 03/23 | NOVOCURE : Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 S.. | PU |
| 02/28 | Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technologic.. | BU |
| 02/24 | Novocure's General Counsel Resigns After 10 Years of Service | BU |
| 02/24 | NOVOCURE : Q4 Earnings Snapshot | AQ |
| 02/24 | NOVOCURE : Invested record $201 million in 2021 in research and development initiatives in.. | PU |
| 02/24 | New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response | BU |
| 02/24 | Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Compa.. | BU |
| 02/24 | NOVOCURE LTD MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
O.. | AQ |
| 01/10 | NOVOCURE : DMC interim analysis for INNOVATE-3 pivotal trial in ovarian cancer anticipated.. | PU |
| 01/10 | Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provi.. | BU |
| 01/04 | Novocure to Participate in the 40th Annual J.P. Morgan Healthcare Conference | BU |
| 2021 | NOVOCURE LTD : Other Events (form 8-K) | AQ |
| 2021 | NOVOCURE : Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New H.. | PU |
| 2021 | Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New .. | BU |
| 2021 | NOVOCURE LTD : Entry into a Material Definitive Agreement, Other Events, Financial Stateme.. | AQ |
| 2021 | Novocure Announces 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research P.. | BU |
| 2021 | Novocure to Participate in Two Upcoming Investor Conferences | BU |
| 2021 | Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treati.. | BU |
| 2021 | Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncol.. | BU |
| 2021 | 2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblasto.. | BU |
| 2021 | NOVOCURE : Q3 Earnings Snapshot | AQ |
| 2021 | NOVOCURE LTD Management's Discussion and Analysis of Financial Condition and Results
o.. | AQ |
| 2021 | Novocure Reports Third Quarter 2021 Financial Results and Provides Company Update - For.. | PU |
| 2021 | Novocure Reports Third Quarter 2021 Financial Results and Provides Company Update | BU |
| 2021 | Novocure Announces Last Patient Enrolled in Phase 3 Pivotal INNOVATE-3 Trial of Tumor T.. | BU |
| 2021 | NOVOCURE : Announces 15 Presentations at the American Society for Radiation Oncology 2021 .. | BU |
| 2021 | NOVOCURE : to Report Third Quarter 2021 Financial Results | BU |
| 2021 | NOVOCURE : and Zai Lab Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Trea.. | BU |
| 2021 | NOVOCURE : Zai Lab and Novocure Announce Last Patient Enrolled in Phase 2 Pilot Trial of T.. | AQ |
| 2021 | NOVOCURE : Announces Clinical Trial Collaboration with Roche to Evaluate Tumor Treating Fi.. | BU |
| 2021 | NOVOCURE : FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System fo.. | BU |
| 2021 | NOVOCURE : to Participate in the 2021 Wells Fargo Virtual Healthcare Conference | BU |
| 2021 | NOVOCURE : Appoints Bill Burke as Chief Human Resources Officer | BU |
| 2021 | NOVOCURE : Q2 Earnings Snapshot | AQ |
| 2021 | NOVOCURE : Management's Discussion and Analysis of Financial Condition and Results of Oper.. | AQ |
| 2021 | NOVOCURE : Reports Second Quarter 2021 Financial Results and Provides Company Update | BU |
| 2021 | NOVOCURE : Announces Recipients of 3rd Annual AACR-Novocure : Grants for Tumor Treating Fi.. | BU |
| 2021 | NOVOCURE : to Report Second Quarter 2021 Financial Results | BU |
| 2021 | NOVOCURE : Presents Final Safety and Efficacy Results from its Phase 2 Pilot HEPANOVA Tria.. | BU |
| 2021 | NOVOCURE : Initiates Usability Study for Flexible Torso Array | BU |
| 2021 | NOVOCURE LTD : Change in Directors or Principal Officers, Submission of Matters to a Vote .. | AQ |
| 2021 | NOVOCURE : Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate.. | BU |
| 2021 | NOVOCURE : Announces FDA Approval of IDE Supplement for Phase 3 Pivotal LUNAR Trial of Tum.. | BU |
| 2021 | NOVOCURE : Interim analysis for phase 3 pivotal LUNAR trial in non-small cell lung cancer .. | PU |
| 2021 | NOVOCURE : Management's Discussion and Analysis of Financial Condition and Results of Oper.. | AQ |
| 2021 | NOVOCURE : Q1 Earnings Snapshot | AQ |
| 2021 | NOVOCURE : Reports First Quarter 2021 Financial Results and Provides Company Update | BU |
| 2021 | NOVOCURE : Announces FDA IDE Approval and Steering Committee for KEYNOTE-B36 Trial Evaluat.. | BU |
| 2021 | NOVOCURE LTD : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
